Loading

Annals of Vascular Medicine and Research

Astrocytic Ca2+ Signaling and its Role in Modulating Cerebral Blood Flow

Review Article | Open Access

  • 1. Dalton Cardiovascular Research Center, USA
  • 2. Department of Bioengineering, University of Missouri-Columbia, USA
+ Show More - Show Less
Corresponding Authors
Shinghua Ding, Dalton Cardiovascular Research Center, Department of Bioengineering, University of Missouri-Columbia, 134 Research Park Drive, Columbia
Citation

Ding S (2014) Astrocytic Ca2+ Signaling and its Role in Modulating Cerebral Blood Flow. Ann Vasc Med Res 1(2): 1006

Abbreviations

GAFP: glial fibrillary acidic protein; CNS: central nervous system; 2-P: two-photon; L1: layer 1; L2/3: layer 2/3; GPCRs: G-protein coupled receptors; mGluR5: metabotropic glutamate receptors; PLC/IP3 : phospholipase-C/inositol 1,4,5-triphosphate; TRP: transient receptor potential; NMDARs: GECIs: genetically encoded Ca2+ indicators; CBF: cerebral blood flow; PLA2: phospholipase A2; BG cells: Bergmann glial cells; Kir channel: inward rectifier K+ channel; COX1: cyclooxygenase; fMRI: Functional magnetic resonance imaging

Introduction

Astrocytes are predominant glial cell type in the central nervous system (CNS) [1-3]. Protoplasmic astrocytes in grey matter and fibrous astrocytes in white matter are the major type of astrocytes which are morphologically different. Protoplasmic astrocytes are complex (sponge like) and highly branched with numerous fine processes and their endfeet wrap around blood vessels, while fibrous astrocytes are less complex and have thicker and less branched processes. Under normal conditions, protoplasmic astrocytes occupy distinct non-overlapping domains in vivo, and their processes completely wrap or ensheath synapses as well as blood vessels [4-6]. Studies using immunofluorescence labeling of neuronal somata in mouse brains revealed that a single astrocyte enwraps on average four neuronal somata with an upper limit of eight. Halassa et al. [5] determined from singleneuron dye-fills that one astrocyte contacts 300–600 neuronal dendrites. The processes from an individual astrocyte envelope approximately 140,000 synapses from multiple neurons [6]. Thus astrocytes can be stimulated by synaptic activities. On the other hand, it has been known for a long time that astrocytes and blood vessel have intimate anatomic relationship. Recent studies using different approaches including fluorescence imaging and electron microscopy revealed that the cerebral vascular surface is almost completely covered by astrocytic endfeet [7-10]. In vivo imaging using 2-P fluorescence microscopy also indicate that astrocyte endfeet wrap around the blood vessels in the mouse brain (Figure 1). Importantly, the endfeet of perivascular astrocytes express high levels of aquaporin and connexin 43 [7]. The spatial occupation and the intimate contact with both synapses and blood vessels render astrocytes as ideally situated to relay neuronal signals to blood vessels and regulate cerebral blood flow. This article reviews the astrocytic Ca2+ signaling pathway and recent advances regarding the role of Ca2+ signaling in the regulation of cerebral blood flow (CBF). The various aspects of neurovascular coupling and the signaling pathways have been reviewed previously [11,12]. Analysis of data from different studies (especially from those in vivo studies) suggests that the involvement of astrocytic Ca2+ in functional hyperemia can be affected by tissue metabolism, animal species, age, brain region and wakefulness of animals. Thus the precise mechanisms by which astrocytic Ca2+ regulates cerebral blood flow can only be elucidated in a defined preparation.

Astrocytes and astrocytic Ca2+ signaling in the CNS

It is well known that astrocytes act as a K+ sink to maintain extracellular K+ homeostasis [13] and remove glutamate from the synaptic cleft by their glutamate transporters to avoid glutamate toxicity [14-16]. Astrocytes also provide nutritional and structural support for neurons. Some astrocytes express the glial fibrillary acidic protein (GFAP), which is used as a specific marker to distinguish them from other cell types; however, its expression levels are different in astrocytes in different regions. For example, under normal conditions, cortical astrocytes express much lower levels of GFAP than do protoplasmic astrocytes in the hippocampus of a mouse brain, although the densities of astrocytes in these two regions are similar [17,18]. It is also clear now that not all astrocytes express GFAP and vice versa, not all cells that express GFAP are astrocytes [19]. It has been recently shown that spinal cord astrocytes express region specific genes that are functionally different, e.g., a recent study revealed that ventral astrocytes in mouse spinal cord express Semaphorin 3a that is important for sensorimotor circuit organization [20]. Electrophysiological recordings also showed that astrocytes even in the same region have differential patterns of current-voltage relationship known as outward rectifying astrocytes and variably rectifying astrocytes [21]. Similarly, in vivo intracellular recording of astrocytic membrane potential revealed a significant variation in fluctuations depending on the local field potential state and cell body location [22]. Astrocytes also exhibit regional heterogeneity in spontaneous Ca2+ signaling. Using two photon (2-P) laser-scanning fluorescence microscopy, Takata and Hirase [23] used an anesthetized adult rat to show how the astrocytes in the cortical layer 1 (L1) exhibited distinct Ca2+ dynamics in vivo when compared to astrocytes in the cortical layer 2/3 (L2/3). They found that astrocytes in L1 had nearly doubled the Ca2+ activity of astrocytes in L2/3 [23]. Furthermore, Ca2+ fluctuations in the processes within an astrocyte were independent in L1, while those in L2/3 were more synchronous [23]. In urethane, anesthetized young mice (P9-25), hippocampal astrocytes exhibited synchronized Ca2+ oscillations and intercellular waves [24,25]. Furthermore, subcellular Ca2+ analysis revealed a complex dynamics in different domains within an astrocyte [26,27]. The difference in astrocytic Ca2+ activities in different brain regions and different microdomains within an astrocyte reflects a functional heterogeneity, which may be the result of different neuronal activities or synaptic integrations, microenvironment and/or different properties of astrocytes per se. These findings demonstrate that astrocytes in the CNS are heterogeneous in morphology, molecular expression, and function.

It was discovered more than two decades ago that cultured astrocytes could mediate Ca2+ signaling (i.e., transient Ca2+ increase) [28,29], suggesting that astrocytes can play more active roles in the CNS than previously found. More recent studies using 2-P microscopy have found that astrocytes can mediate Ca2+ signaling and intercellular waves in vivo by the activation of a variety of G-protein coupled receptors (GPCRs) including Group I metabotropic glutamate receptors (mGluRs) [30-32], P2Y receptors [32-36], GABAB receptors (GABABRs) [33;37], α1-adrenergic receptors [38-40], cholinergic receptors [41;42], and dopamine receptors [43;44]. GPCR-mediated Ca2+ signaling is now considered a primary form of Ca2+ signaling pathways in astrocytes as shown by Ca2+ imaging. GPCR stimulation activates phospholipase-C/inositol 1,4,5-triphosphate (PLC/IP3 ) pathway to release Ca2+ from the ER through the activation of IP3 Rs [1,3,45] for Ca2+ signaling pathways (for review see Verkhratsky et al. [46] and Ding [47]). Among the three subtypes of IP3 R (IP3 R1-3), IP3 R2 seems to be predominant in stimulating astrocytes in the rodent brain [48-50]. IP3 R2 knock-out (IP3 R2 KO) mice did not exhibit GPCR agonists-evoked Ca2+ release in astrocytes in brain slice preparation and in studies of live mice, demonstrating that IP3 R2 is a key mediator of intracellular Ca2+ release in astrocytes [36;45]. In addition to GPCR stimulations, astrocytic Ca2+ signals can also be evoked by sensory stimulations, mechanical stimulations, and photolysis of caged compounds [30,32,35,51,52]. Sensory stimulations, including whisker deflection [35], locomotion [53,54], limb stimulation [38;55;56], light illumination of visual cosrtex [42;57], and odor stimulation of olfactory glomeruli [8] can all induce Ca2+ elevation and intercellular waves in astrocytes in vivo in anesthetized animals. A number of plasma membrane proteins also control Ca2+ homeostasis through regulating Ca2+ influx from the extracellular side. Those proteins include the Na+ / Ca2+ exchanger [58-60], plasma membrane Ca2+ ATPase [58], store operated channels [61], P2X purinoceptors [62,63], transient receptor potential A (TRPA) [64] and C (TRPC) channels [61,65- 67], and N-methyl-D-aspartate (NMDA) receptors [63]. Astrocytic Ca2+ signaling has been extensively studied in cultured astrocytes as well as in live animals using fluorescence imaging. Both synthetic organic Ca2+ probes and genetically encoded Ca2+ indicators (GECIs) can be used to label astrocytes. The acetoxymethyl (AM) ester form of synthetic organic Ca2+ indicators such as fluo-4, Oregon green BAPTA-1 (OGB), Rhod2, or x-Rhod-1 have been largely used for in vitro and in vivo Ca2+ imaging due to their high sensitivity and speed [23,30,32- 35,41,51,68-72]. The selective labeling of astrocytes in vivo by synthetic organic Ca2+ indicators can be confirmed by an astrocyte selective dye sulforhodamine 101 (SR101) [70]. Recently developed GECIs including FRET-based GECIs such as YC3.6 and intensity-based single-fluorophore GECIs such as GCaMP provided an alternative way to image Ca2+ signaling in astrocytes in vivo. The major advantage for using GECIs is that they can be selectively expressed in astrocytes using an astrocyte-specific promoter. They can be expressed in astrocytes using viral transduction, in utero electroporation or transgenic mice [40,73-78]. Astrocyte-specific expression of GECIs using adeno-associated viral vectors can be achieved by astrocytespecific promoters [18,76,79]. The most recently developed GCaMP5 and GCaMP6 yielded a cytosolic Ca2+ increase in a neuron after triggering a single action potential and sensory stimulation [75,80]. Transgenic mice expressing floxed GCaMP3 and GCaMP5G have been crossed with Cre mice having neuronand astrocyte-specific promoters for neuronal and astrocytic Ca2+ imaging [40,74,77]. For astrocytic specific expression of GCaMP3 and GCaMP5G, GFAP-Cre mice are commercially available [81,82]. Although Ca2+ signals in the processes of astrocytes can be readily observed using bulky loading of organic synthetic Ca2+ indicators [30,33-35,38], GECIs especially GCaMP can reveal more detailed features of Ca2+ signaling in microdomains than organic synthetic Ca2+ indicators [40,76-78]. Since GECIs can be expressed in astrocytes for prolonged times, another advantage for using GECIs is that it is feasible to conduct long-term and repeated in vivo Ca2+ imaging in astrocytes. Usually, for in vivo imaging, an open skull or thin skull cranial window in the cortex must be prepared for optical access and/or loading organic Ca2+ indicators [68,83-86]. It is also worth mentioning that GECIs are also advantageous over synthetic organic Ca2+ indicators when they are used for mitochondrial Ca2+ uptake as GECIs can be selectively targeted in mitochondrial matrix, overcoming the partial localization of synthetic organic Ca2+ indicators in the cytosol [87,88].

The role of astrocytic Ca2+ signaling in the regulation of CBF CBF

CBF is regulated by cerebrovascular autoregulation and functional hyperemia. The latter refers to matched delivery of blood flow to the brain regions with different activity levels. Given that Ca2+ signaling is the primary form of astrocytic excitability, the role of astrocytic Ca2+ signaling in regulating CBF has been studied using in vitro and in vivo preparations.

Using brain slices, Stobart et al. [89] and Zonta et al.[90] found that Ca2+ elevation in astrocytes induced by neuronal afferent stimulation and photolysis of caged Ca2+ induced vasodilation. Studies from brain and retina slices suggest that the polarity of astrocytic Ca2+-dependent regulation of blood flow is dictated by tissue metabolism [91-93]. Brain slice study has also shown that the levels of astrocytic Ca2+ increase determine vessel dilation or constriction regardless of the mechanism by which astrocytic endfeet Ca2+ is elevated [94]. The modest increases in Ca2+ induced dilation, whereas larger increases lead to constriction. These studies suggest complex mechanisms of blood flow regulation by astrocytic Ca2+ signals [11]. Different pathways and vasoactive mediators derived from astrocytes are involved in vessel dilation and constriction. Synaptically released glutamate activates metabotropic glutamate receptors (mGluRs) and stimulates astrocytic Ca2+ elevation that activates downstream pathways through phospholipase A2 (PLA2). PLA2 mediates arachidonic acid generation and subsequently three types of metabolite:1) Prostaglandins (PG) by cyclooxygenase (COX1) [51,90,91] and 2) exoxyeicosatrienoic acids (EETs) by cytochrome P450 (CYP-450) epoxygenase [93] in astrocytes dilate vessels, and 3) 20-hydroxyeicosatetraeonic acid (20-HETE) by CYP-450 ω-hydroxylase in smooth muscle, which constricts vessels [91,93]. Nitric oxide (NO) can regulate vascular tone by inhibiting the synthesis of the vasoconstricting 20-HETE as well as the vasodilating EETs [95]. Oxygen levels affect the vasoactive mediators [91,92]. When oxygen levels are lowered and astrocyte Ca2+ concentration is increased, glycolysis is dominated in astrocytic energy metabolism and lactate is accumulated in extracellular space. Extracellular lactate attenuates transportermediated uptake of extracellular prostaglandin E2 , leading to accumulation and subsequent vasodilation [91]. These studies indicate that cellular energy metabolism regulate astrocytic Ca2+ mediated vascular changes. Astrocytic K+ also plays a role in vascular tone. Using rat brain slice preparations, it was reported that neuronal activity-induced astrocytic Ca2+ signals opened large-conductance Ca2+-sensitive K+ (BK) channels in astrocytic endfeet [96]. BK channels in turn activated inward rectifier K+ (Kir) channels in smooth muscle cells and cause vasodilation. However, further study showed that a high concentration of astrocytic Ca2+ (induced by either uncaging or electric field stimulations) and perivascular K+ caused vessel constrictions, while low astrocytic Ca2+ perivascular K+ caused vasodilation [94]. A study from retinal slice preparation provided contradictive evidence for the role of astrocytic K+ in functional hyperemia. Depolarization-induced release of astrocytic K+ from endfeet did not cause vasodilation in arterioles [97]. Furthermore, the magnitude of light-evoked vasodilations was identical in Kir4.1 knock-out and wild-type animals, indicating that astrocytic K+ in the retina does not contribute to neurovascular coupling. Thus the role of astrocytic K+ in regulating functional hyperemia is not defined.

While brain slice preparations provide ready access for pharmacological manipulations, Ca2+ imaging and patch clamp recording, a major drawback in using brain slice preparations is that arterioles are usually preconstricted and lack spontaneous tone. In vivo approach using 2-P microscopy to image cellular Ca2+ signals and blood flow through a cranial window provides a unique tool to study the mechanism of neurovascular coupling in the intact brain. Different studies indicate that Ca2+ evaluation in astrocytes is involved in functional hyperemia. Takano et al. reported that photolysis of caged Ca2+ in the endfeet of astrocytes induced rapid dilation of the arteries, but not of the veins and capillaries in the mouse cortex [51]. Similar phenomenon was observed following neuronal stimulation. Electrical stimulation evoked an increase in local neuronal activity and a widespread increase in astrocytic Ca2+ and was associated with vasodilation. Combined with pharmacological manipulation, they further showed that astrocyte-mediated vasodilation is partially dependent on COX-1 activity. In cerebellum, Ca2+ signals of Bergmann glial (BG) cells are associated with motor behavior and neuronal activity [53]. In awake and behaving mice, BG cells have exhibited three different forms of Ca2+ excitation: flares, bursts, and sparkles. Bursts and sparkles were ongoing in awake mice at rest, whereas flares were initiated during locomotor behavior. Locomotor performance initiated synchronized Ca2+ signals in the network of BG cells. Motor behavior induced astrocytic Ca2+ flares were correlated with blood flow increase, which can be attenuated by tetrodotoxin through the inhibition of neuronal activity. Thus, the specific animal behavior noted in the experiments dealing with awake and behaving mice dictated Ca2+ excitability in BG cells and vascular response. Odor stimulation also induced Ca2+ transients in astrocyte endfeet and an associated dilation of upstream arterioles; furthermore, Ca2+ elevations in astrocytes and functional hyperemia depended on mGluR5 in astrocytes and cyclooxygenase activation [8]. Electrical stimulation of a forepaw of isoflurane-anesthetized mice induced vasodilation and an astrocytic Ca2+ increase in the forepaw region of their primary somatosensory cortex [36]. However, a recent study showed that IP3 R2 KO mice exhibited normal functional hyperemia in the same tests [36], indicating that the stimulus-induced vasodilation is independent of IP3 R-mediated Ca2+ increase since IP3 R2 KO mice lack cytosolic Ca2+ elevation in astrocytes. In addition, it was observed that the onset of vasodilation preceded astrocytic Ca2+ increase. Consistent with this study, Takata reported that IP3 R2 knockout mice showed similar changes in CBF with WT mice after a brief electrical stimulation of the nucleus basalis of Meynert (NBM), the primary source of cholinergic projection to the cerebral cortex [98]. Moreover, whisker stimulation resulted in similar degrees of CBF increase in IP3 R2 KO mice and WT mice. In vivo electrophysiological recording on dentate gyrus and fMRI showed that WT and IP3 R2 KO mice exhibited no difference in electrical responses and BOLD signals after electrical stimulation of perforant pathway [99]. Using in vivo 2-P imaging on awake mice and astrocyte-specific expression of GCaMP6s, a very recent study from Bonder and McCarthy further confirmed that IP3 R2-mediated Ca2+ signaling is not critically involved in meditating functional hyperemia [100]. These results from in vivo indicate that neural activity-driven CBF modulation could occur without large cytosolic increases of Ca2+ in astrocytes. Similarly, inhibition of group I mGluRs did not affect transient hemodynamic responses following a brief whisker stimulation in rats under isoflurane anesthesia [101]. This study suggests that group I mGluRs, whether they are expressed in neurons and/or astrocytes, do not play a role in early hemodynamic responses following sensory stimulation in rats, which is contradictive to other in vitro and in vivo studies [8,51,90] and raises the question whether neurovascular coupling involves signaling from neurons to glial cells to blood vessels.

Discussion and Conclusions

Several in vitro and in vivo studies demonstrated that astrocytic Ca2+ signals were involved in the regulation of CBF. However, data from different studies were not consistent. The fact that from multiple in vivo studies, IP3 R2 KO mice do not show a difference from the wild type mice in CBF after sensory and electrical stimulation suggests that functional hyperemia induced by these stimulations is mainly neuronal dependent, and IP3 R2-mediated Ca2+ increase may not be sufficient enough to exert an additional effect on the onset of vasodilation [36,98- 100]. One must realize that anesthetized or awake animals might have different responses to functional hyperemia as astrocytes exhibit different Ca2+ properties in anesthetized versus awake mice. In awake mice, cortical astrocytes exhibited much higher frequency of spontaneous Ca2+ signaling in the cell body and processes than in mice anesthetized by isoflurane, ketamine and urethane [34]. In addition, spontaneous somatic Ca2+ signals in astrocytes were expressed as intercellular wave characterized as synchronized Ca2+ elevation in the astrocyte network in awake mice. Thus, synchronization of cortical astrocytic Ca2+ activity is a hallmark of wakefulness of an animal and the concentration of vasoactive mediators released from astrocytes might also depend on the wakefulness of an animal. The role of astrocytic Ca2+ in CBF regulation might also be regional difference while most in vivo studies were conducted on the somatosensory cortex. Age of animals could also be a factor. A recent study showed that spontaneous Ca2+ wave in BG increased with age [102], thus, the threshold for the glial Ca2+ in aged mice to exert an effect on neurovascular couple might be different from young mice. The role of mGluR5 in CBF regulation is also controversial. Inhibition of group I mGluR reduced sensory stimulation-induced astrocytic Ca2+ signals in cortex and olfactory glomeruli [8,51,90], suggesting that signaling from neuron to glial cells to blood vessel is involved in neurovascular coupling. However, another study showed that the antagonists of mGluR5 did not affect functional hyperemia, suggesting that neuron-derived glutamate is not involved in hemodynamic response to sensory stimulation [101]. Since young mice express much higher mGluR5 than adult mice [32], the discrepancy could be due to the age difference of animals used. Thus it is unclear to what extent functional hyperemia is dependent on glutamate-stimulated astrocytic Ca2+. On the other hand, functional hyperemia is multifactorial, involving neurons, glial cells, smooth muscle cells and endothelial cells; furthermore, their coordinated actions are required. Thus a unifying mechanism can only be determined using a defined preparation. Tissue metabolism, animal species, age, brain region for study, and wakefulness of animals may all affect the involvement of astrocytic Ca2+ signaling in the regulation of CBF. It is also worth pointing out that although KO mouse models are particularly useful for studies astrocytic Ca2+ signaling and neuron-glial vasculature coupling, functional and developmental compensation may eliminate the phenotypic effect [100]. As multiple studies with negative results were from the same IP3 R2 KO mice, it is important to develop and use other animal models to further clarify the role and involvement of astrocytic IP3 R2-mediated Ca2+ in the regulation of CBF. Inducible IP3 R2 KO mice might be a direction as the target gene of interest can be inactivated in specific cell types at specific time points, thus reducing or eliminating the phenotypic effect. However, inducible IP3 R2 KO mice are not available for the time being. Another approach is to use viral transduction to disrupt IP3 R-mediated Ca2+ signaling in astrocytes by overexpressing IP3 sponge and IP3 phosphatase specifically in astrocytes [18,88,103], however, it is expectable that the effect can only be achieved when enough number of astrocytes around the blood vessels is transduced. While we have discussed the involvement of astrocytic Ca2+ in functional hyperemia in healthy animals, several studies showed that astrocytes have increased Ca2+ signals in the mouse models of neural diseases (for review see Ding [17]). Using in vivo 2-P imaging, Ding et al. [30,33] reported that astrocytes exhibited enhanced Ca2+ signaling and intercellular waves in vivo after status epilepticus and photothrombosis-induced ischemic stroke. Traumatic brain injury [104] and Alzheimer diseases [105] also dramatically increase astrocytic Ca2+ signaling. Therefore, it is important to determine whether and how astrocytic Ca2+ plays a role in CBF regulation in neural diseases. Understanding the mechanisms by which enhanced astrocytic Ca2+ isinduced and the role of astrocytic Ca2+ is played in the regulation of CBF should provide therapeutic implications for these and other neural diseases.

Acknowledgements

This work was supported by the National Institutes of Health [R01NS069726] and the American Heart Association Midwest Affiliate Grant in Aid award [13GRANT17020004] to SD.

REFERENCES

1. Agulhon C, Petravicz J, McMullen AB, Sweger EJ, Minton SK, Taves SR. What is the role of astrocyte calcium in neurophysiology? Neuron. 2008; 59: 932-946.

2. Barres BA. The mystery and magic of glia: a perspective on their roles in health and disease. Neuron. 2008; 60: 430-440.

3. Haydon PG. GLIA: listening and talking to the synapse. Nat Rev Neurosci. 2001; 2: 185-193.

4. Wilhelmsson U, Bushong EA, Price DL, Smarr BL, Phung V, Terada M. Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc Natl Acad Sci U S A. 2006; 103: 17513-17518.

5. Halassa MM, Fellin T, Takano H, Dong JH, Haydon PG. Synaptic islands defined by the territory of a single astrocyte. J Neurosci. 2007; 27: 6473-6477.

6. Bushong EA, Martone ME, Jones YZ, Ellisman MH. Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci. 2002; 22: 183-192.

7. Simard M, Arcuino G, Takano T, Liu QS, Nedergaard M. Signaling at the gliovascular interface. J Neurosci. 2003; 23: 9254-9262.

8. Petzold GC, Albeanu DF, Sato TF, Murthy VN. Coupling of neural activity to blood flow in olfactory glomeruli is mediated by astrocytic pathways. Neuron. 2008; 58: 897-910.

9. Mathiisen TM, Lehre KP, Danbolt NC, Ottersen OP. The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia. 2010; 58: 1094-1103.

10. Kacem K, Lacombe P, Seylaz J, Bonvento G. Structural organization of the perivascular astrocyte endfeet and their relationship with the endothelial glucose transporter: A confocal microscopy study. GLIA 1998; 23: 1-10.

11. Attwell D, Buchan AM, Charpak S, Lauritzen M, Macvicar BA, Newman EA. Glial and neuronal control of brain blood flow. Nature. 2010; 468: 232-243.

12. Filosa JA, Iddings JA. Astrocyte regulation of cerebral vascular tone. Am J Physiol Heart Circ Physiol. 2013; 305: H609-619.

13. Djukic B, Casper KB, Philpot BD, Chin LS, McCarthy KD. Conditional Knock-Out of Kir4.1 Leads to Glial Membrane Depolarization, Inhibition of Potassium and Glutamate Uptake, and Enhanced ShortTerm Synaptic Potentiation. J Neurosci. 2007; 27: 11354-11365.

14. Huang YH, Bergles DE. Glutamate transporters bring competition to the synapse. Curr Opin Neurobiol. 2004; 14: 346-352.

15. Bergles DE, Diamond JS, Jahr CE. Clearance of glutamate inside the synapse and beyond. Curr Opin Neurobiol. 1999; 9: 293-298.

16. Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001; 65: 1-105.

17. Ding S. In vivo astrocytic Ca2+ signaling in health and brain disorders. Future Neurol. 2013; 8: 529-554.

18. Xie Y, Wang T, Sun GY, Ding S. Specific disruption of astrocytic Ca2+ signaling pathway in vivo by adeno-associated viral transduction. Neuroscience. 2010; 170: 992-1003.

19. Oberheim NA, Goldman SA, Nedergaard M. Heterogeneity of astrocytic form and function. Methods Mol Biol. 2012; 814: 23-45.

20. Molofsky AV, Kelley KW2, Tsai HH3, Redmond SA4, Chang SM5, Madireddy L6. Astrocyte-encoded positional cues maintain sensorimotor circuit integrity. Nature. 2014; 509: 189-194.

21. Zhou M, Kimelberg HK. Freshly isolated astrocytes from rat hippocampus show two distinct current patterns and different [K(+)] (o) uptake capabilities. J Neurophysiol. 2000; 84: 2746-2757.

22. Mishima T, Hirase H. In vivo Intracellular Recording Suggests That Gray Matter Astrocytes in Mature Cerebral Cortex and Hippocampus Are Electrophysiologically Homogeneous. The Journal of Neuroscience. 2010; 30: 3093-3100.

23. Takata N, Hirase H. Cortical layer 1 and layer 2/3 astrocytes exhibit distinct calcium dynamics in vivo. PLoS One. 2008; 3: e2525.

24. Kuga N, Sasaki T, Takahara Y, Matsuki N, Ikegaya Y. Large-scale calcium waves traveling through astrocytic networks in vivo. J Neurosci. 2011; 31: 2607-2614.

25. Sasaki T, Kuga N, Namiki S, Matsuki N, Ikegaya Y. Locally synchronized astrocytes. Cereb Cortex. 2011; 21: 1889-1900.

26. Di Castro MA, Chuquet J, Liaudet N, Bhaukaurally K, Santello M, Bouvier D. Local Ca2+ detection and modulation of synaptic release by astrocytes. Nat Neurosci. 2011; 14: 1276-1284.

27. Wu YW, Tang X, Arizono M, Bannai H, Shih PY, Dembitskaya Y2. Spatiotemporal calcium dynamics in single astrocytes and its modulation by neuronal activity. Cell Calcium. 2014; 55: 119-129.

28. Cornell-Bell AH, Finkbeiner SM, Cooper MS, Smith SJ. Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. 1990; 247: 470-473.

29. Parpura V, Basarsky TA, Liu F, Jeftinija K, Jeftinija S, Haydon PG. Glutamate-mediated astrocyte-neuron signalling. Nature. 1994; 369: 744-747.

30. Ding S, Fellin T, Zhu Y, Lee SY, Auberson YP, Meaney DF. Enhanced astrocytic Ca2+ signals contribute to neuronal excitotoxicity after status epilepticus. J Neurosci. 2007; 27: 10674-10684.

31. Fellin T, Pascual O, Gobbo S, Pozzan T, Haydon PG, Carmignoto G. Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron. 2004; 43: 729-743.

32. Sun W, McConnell E, Pare JF, Xu Q, Chen M, Peng W. Glutamatedependent neuroglial calcium signaling differs between young and adult brain. 2013; 339: 197-200.

33. Ding S, Wang T, Cui W, Haydon PG. Photothrombosis ischemia stimulates a sustained astrocytic Ca2+ signaling in vivo. Glia. 2009; 57: 767-776.

34. Thrane AS, Rangroo Thrane V, Zeppenfeld D, Lou N, Xu Q, Nagelhus EA. General anesthesia selectively disrupts astrocyte calcium signaling in the awake mouse cortex. Proc Natl Acad Sci U S A. 2012; 109: 18974- 18979.

35. Wang X, Lou N, Xu Q, Tian GF, Peng WG, Han X. Astrocytic Ca2+ signaling evoked by sensory stimulation in vivo. Nat Neurosci. 2006; 9: 816-823.

36. Nizar K, Uhlirova H, Tian P et al. In vivo Stimulus-Induced Vasodilation Occurs without IP3 Receptor Activation and May Precede Astrocytic Calcium Increase. The Journal of Neuroscience. 2013; 33: 8411-8422.

37. Meier SD, Kafitz KW, Rose CR. Developmental profile and mechanisms of GABA-induced calcium signaling in hippocampal astrocytes. Glia. 2008; 56: 1127-1137.

38. Bekar LK, He W, Nedergaard M. Locus coeruleus alpha-adrenergicmediated activation of cortical astrocytes in vivo. Cereb Cortex. 2008; 18: 2789-2795.

39. Ding F, O’Donnell J, Thrane AS, Zeppenfeld D, Kang H, Xie L. α1- Adrenergic receptors mediate coordinated Ca2+ signaling of cortical astrocytes in awake, behaving mice. Cell Calcium. 2013; 54: 387-394.

40. Paukert M, Agarwal A2, Cha J3, Doze VA4, Kang JU3, Bergles DE5. Norepinephrine controls astroglial responsiveness to local circuit activity. Neuron. 2014; 82: 1263-1270.

41. Takata N, Mishima T, Hisatsune C, Nagai T, Ebisui E, Mikoshiba K. Astrocyte calcium signaling transforms cholinergic modulation to cortical plasticity in vivo. J Neurosci. 2011; 31: 18155-18165.

42. Chen N, Sugihara H, Sharma J, Perea G, Petravicz J, Le C. Nucleus basalis-enabled stimulus-specific plasticity in the visual cortex is mediated by astrocytes. Proc Natl Acad Sci U S A. 2012; 109: E2832- 2841.

43. Haydon PG, Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev. 2006; 86: 1009-1031.

44. Ni Y, Malarkey EB, Parpura V. Vesicular release of glutamate mediates bidirectional signaling between astrocytes and neurons. J Neurochem. 2007; 103: 1273-1284.

45. Petravicz J, Fiacco TA, McCarthy KD. Loss of IP3 receptor-dependent Ca2+ increases in hippocampal astrocytes does not affect baseline CA1 pyramidal neuron synaptic activity. J Neurosci. 2008; 28: 4967-4973.

46. Verkhratsky A, Rodríguez JJ, Parpura V. Calcium signalling in astroglia. Mol Cell Endocrinol. 2012; 353: 45-56.

47. Ding S, Sachs F. Single channel properties of P2X2 purinoceptors. J Gen Physiol. 1999; 113: 695-720.

48. Hertle DN, Yeckel MF, Hertle DN, Yeckel MF. Distribution of inositol1,4,5-trisphosphate receptor isotypes and ryanodine receptor isotypes during maturation of the rat hippocampus. 2007; 150: 625- 638.

49. Holtzclaw LA, Pandhit S, Bare DJ, Mignery GA, Russell JT. Astrocytes in adult rat brain express type 2 inositol 1,4,5-trisphosphate receptors. Glia. 2002; 39: 69-84.

50. Sharp AH, Nucifora FC Jr, Blondel O, Sheppard CA, Zhang C, Snyder SH. Differential cellular expression of isoforms of inositol 1,4,5-triphosphate receptors in neurons and glia in brain. J Comp Neuro. l 1999; 406: 207-220.

51. Takano T, Tian GF, Peng W, Lou N, Libionka W, Han X. Astrocytemediated control of cerebral blood flow. Nat Neurosci. 2006; 9: 260- 267.

52. Tian GF, Azmi H, Takano T, Xu Q, Peng W, Lin J. An astrocytic basis of epilepsy. Nat Med. 2005; 11: 973-981.

53. Nimmerjahn A, Mukamel EA, Schnitzer MJ. Motor behavior activates Bergmann glial networks. Neuron. 2009; 62: 400-412.

54. Dombeck DA, Khabbaz AN, Collman F, Adelman TL, Tank DW. Imaging large-scale neural activity with cellular resolution in awake, mobile mice. Neuron. 2007; 56: 43-57.

55. Winship IR, Plaa N, Murphy TH. Rapid astrocyte calcium signals correlate with neuronal activity and onset of the hemodynamic response in vivo. J Neurosci. 2007; 27: 6268-6272.

56. Ghosh A, Wyss MT, Weber B. Somatotopic astrocytic activity in the somatosensory cortex. Glia. 2013; 61: 601-610.

57. Schummers J, Yu H, Sur M. Tuned responses of astrocytes and their influence on hemodynamic signals in the visual cortex. 2008; 320: 1638-1643.

58. Reyes RC, Verkhratsky A, Parpura V. Plasmalemmal Na+ /Ca2+ exchanger modulates Ca2+-dependent exocytotic release of glutamate from rat cortical astrocytes. ASN Neuro. 2012; 4:e00075.

59. .Takuma K, Ago Y, Matsuda T. The glial sodium-calcium exchanger: a new target for nitric oxide-mediated cellular toxicity. Curr Protein Pept Sci. 2013; 14: 43-50.

60. Kirischuk S, Parpura V, Verkhratsky A. Sodium dynamics: another key to astroglial excitability? Trends Neurosci. 2012; 35: 497-506.

61. .Linde CI, Baryshnikov SG, Mazzocco-Spezzia A, Golovina VA. Dysregulation of Ca2+ signaling in astrocytes from mice lacking amyloid precursor protein. Am J Physiol Cell Physiol. 2011; 300: C1502-1512.

62. Illes P, Verkhratsky A, Burnstock G, Franke H. P2X receptors and their roles in astroglia in the central and peripheral nervous system. Neuroscientist. 2012; 18: 422-438.

63. Palygin O, Lalo U, Verkhratsky A, Pankratov Y. Ionotropic NMDA and P2X1/5 receptors mediate synaptically induced Ca2+ signalling in cortical astrocytes. Cell Calcium. 2010; 48: 225-231.

64. Shigetomi E, Tong X, Kwan KY, Corey DP, Khakh BS. TRPA1 channels regulate astrocyte resting calcium and inhibitory synapse efficacy through GAT-3. Nat Neurosci. 2011; 15: 70-80.

65. Shirakawa H, Sakimoto S, Nakao K et al. Transient Receptor Potential Canonical 3 (TRPC3) Mediates Thrombin-Induced Astrocyte Activation and Upregulates Its Own Expression in Cortical Astrocytes. The Journal of Neuroscience 2010; 30: 13116-13129.

66. Malarkey EB, Ni Y, Parpura V. Ca2+ entry through TRPC1 channels contributes to intracellular Ca2+ dynamics and consequent glutamate release from rat astrocytes. Glia. 2008; 56: 821-835.

67. Reyes RC, Verkhratsky A, Parpura V. TRPC1-mediated Ca2+ and Na+ signalling in astroglia: differential filtering of extracellular cations. Cell Calcium. 2013; 54: 120-125

68. Ding S. In vivo imaging of Ca2+ signaling in astrocytes using two-photon laser scanning fluorescent microscopy. Methods Mol Biol. 2012; 814: 545-554.

69. Hirase H, Qian L, Barthó P, Buzsáki G. Calcium dynamics of cortical astrocytic networks in vivo. PLoS Biol. 2004; 2: E96.

70. Nimmerjahn A, Kirchhoff F, Kerr JN, Helmchen F. Sulforhodamine 101 as a specific marker of astroglia in the neocortex in vivo. Nature Methods. 2004; 1: 31-37.

71. Aguado F, Espinosa-Parrilla JF, Carmona MA, Soriano E. Neuronal activity regulates correlated network properties of spontaneous calcium transients in astrocytes in situ. J Neurosci. 2002; 22: 9430-9444.

72 .Porter JT, McCarthy KD. Hippocampal astrocytes in situ respond to glutamate released from synaptic terminals. J Neurosci. 1996; 16: 5073-5081.

73. Tian L, Hires SA, Mao T, Huber D, Chiappe ME, Chalasani SH. Imaging neural activity in worms, flies and mice with improved GCaMP calcium indicators. Nat Methods. 2009; 6: 875-881.

74. Zariwala HA, Borghuis BG, Hoogland TM, Madisen L, Tian L, De Zeeuw CI. A Cre-dependent GCaMP3 reporter mouse for neuronal imaging in vivo. J Neurosci. 2012; 32: 3131-3141.

75. Akerboom J, Chen TW, Wardill TJ, Tian L, Marvin JS, Mutlu S. Optimization of a GCaMP calcium indicator for neural activity imaging. J Neurosci. 2012; 32: 13819-13840.

76. Shigetomi E, Bushong EA, Haustein MD et al. Imaging calcium microdomains within entire astrocyte territories and endfeet with GCaMPs expressed using adeno-associated viruses. J Gen Physiol. 2013; 141: 633-647.

77. Gee JM, Smith NA2, Fernandez FR3, Economo MN4, Brunert D4, Rothermel M4. Imaging Activity in Neurons and Glia with a Polr2aBased and Cre-Dependent GCaMP5G-IRES-tdTomato Reporter Mouse. Neuron. 2014; 83: 1058-1072.

78. Haustein MD, Kracun S, Lu XH2, Shih T3, Jackson-Weaver O, Tong X1. Conditions and constraints for astrocyte calcium signaling in the hippocampal mossy fiber pathway. Neuron. 2014; 82: 413-429.

79. Tong X, Shigetomi E, Looger LL, Khakh BS. Genetically encoded calcium indicators and astrocyte calcium microdomains. Neuroscientist. 2013; 19: 274-291.

80. Chen TW, Wardill TJ, Sun Y, Pulver SR, Renninger SL, Baohan A. Ultrasensitive fluorescent proteins for imaging neuronal activity. Nature. 2013; 499: 295-300.

81. Garcia AD, Doan NB, Imura T, Bush TG, Sofroniew MV. GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat Neurosci. 2004; 7: 1233-1241.

82. Chow LM, Zhang J, Baker SJ. Inducible Cre recombinase activity in mouse mature astrocytes and adult neural precursor cells. Transgenic Res. 2008; 17: 919-928.

83. Tian GF, Takano T, Lin JH, Wang X, Bekar L, Nedergaard M. Imaging of cortical astrocytes using 2-photon laser scanning microscopy in the intact mouse brain. Adv Drug Deliv Rev. 2006; 58: 773-787.

84. Zuo Y, Lin A, Chang P, Gan WB. Development of long-term dendritic spine stability in diverse regions of cerebral cortex. Neuron. 2005; 46: 181-189.

85. Holtmaat A, Bonhoeffer T, Chow DK, Chuckowree J, De Paola V, Hofer SB. Long-term, high-resolution imaging in the mouse neocortex through a chronic cranial window. Nat Protoc. 2009; 4: 1128-1144.

86. Yang G, Pan F, Parkhurst CN, Grutzendler J, Gan WB. Thinned-skull cranial window technique for long-term imaging of the cortex in live mice. Nat Protoc. 2010; 5: 201-208.

87. Qiu J, Tan YW, Hagenston AM, Martel MA, Kneisel N, Skehel PA. Mitochondrial calcium uniporter Mcu controls excitotoxicity and is transcriptionally repressed by neuroprotective nuclear calcium signals. Nat Commun. 2013; 4: 2034.

88. Li H, Wang X, Zhang N, Gottipati MK, Parpura V, Ding S. Imaging of mitochondrial Ca2+ dynamics in astrocytes using cell-specific mitochondria-targeted GCaMP5G/6s: Mitochondrial Ca2+ uptake and cytosolic Ca2+ availability via the endoplasmic reticulum store. Cell Calcium (in Press).

89. Stobart JL, Lu L, Anderson HD, Mori H, Anderson CM. Astrocyteinduced cortical vasodilation is mediated by D-serine and endothelial nitric oxide synthase. Proc Natl Acad Sci U S A. 2013; 110: 3149-3154.

90. Zonta M, Angulo MC, Gobbo S, Rosengarten B, Hossmann KA, Pozzan T. Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci. 2003; 6: 43-50.

91. Gordon GR, Choi HB, Rungta RL, Ellis-Davies GC, MacVicar BA. Brain metabolism dictates the polarity of astrocyte control over arterioles. Nature. 2008; 456: 745-749.

92. Mishra A, Hamid A, Newman EA. Oxygen modulation of neurovascular coupling in the retina. Proc Natl Acad Sci U S A. 2011; 108: 17827- 17831.

93. Mulligan SJ, MacVicar BA. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature. 2004; 431: 195-199.

94. Girouard H, Bonev AD, Hannah RM, Meredith A, Aldrich RW, Nelson MT. Astrocytic endfoot Ca2+ and BK channels determine both arteriolar dilation and constriction. Proc Natl Acad Sci U S A. 2010; 107: 3811- 3816.

95. Peng X, Carhuapoma JR, Bhardwaj A, Alkayed NJ, Falck JR, Harder DR. Suppression of cortical functional hyperemia to vibrissal stimulation in the rat by epoxygenase inhibitors. Am J Physiol Heart Circ Physiol. 2002; 283: H2029-2037.

96. Filosa JA, Bonev AD, Straub SV, Meredith AL, Wilkerson MK, Aldrich RW. Local potassium signaling couples neuronal activity to vasodilation in the brain. Nat Neurosci. 2006; 9: 1397-1403.

97. Metea MR, Kofuji P, Newman EA. Neurovascular coupling is not mediated by potassium siphoning from glial cells. J Neurosci. 2007; 27: 2468-2471.

98. Takata N, Nagai T, Ozawa K, Oe Y, Mikoshiba K, Hirase H. Cerebral blood flow modulation by Basal forebrain or whisker stimulation can occur independently of large cytosolic Ca2+ signaling in astrocytes. PLoS One. 2013; 8: e66525.

99. Jego P, Pacheco-Torres J, Araque A2, Canals S1. Functional MRI in mice lacking IP3-dependent calcium signaling in astrocytes. J Cereb Blood Flow Metab. 2014; 34: 1599-1603.

100. Bonder DE, McCarthy KD2. Astrocytic Gq-GPCR-Linked IP3 RDependent Ca2+ Signaling Does Not Mediate Neurovascular Coupling in Mouse Visual Cortex In vivo. J Neurosci. 2014; 34: 13139-13150.

101. Calcinaghi N, Jolivet R, Wyss MT, Ametamey SM, Gasparini F, Buck A. Metabotropic glutamate receptor mGluR5 is not involved in the early hemodynamic response. J Cereb Blood Flow Metab. 2011; 31: e1-10.

102. Mathiesen C, Brazhe A, Thomsen K, Lauritzen M. Spontaneous calcium waves in Bergman glia increase with age and hypoxia and may reduce tissue oxygen. J Cereb Blood Flow Metab. 2013; 33: 161- 169.

103. Kanemaru K, Okubo Y, Hirose K, Iino M. Regulation of neurite growth by spontaneous Ca2+ oscillations in astrocytes. J Neurosci. 2007; 27: 8957-8966.

104. Choo AM, Miller WJ, Chen YC, Nibley P, Patel TP, Goletiani C. Antagonism of purinergic signalling improves recovery from traumatic brain injury. 2013; 136: 65-80.

105. Kuchibhotla KV, Lattarulo CR, Hyman BT, Bacskai BJ. Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. 2009; 323: 1211-1215

Received : 16 Sep 2014
Accepted : 18 Oct 2014
Published : 20 Oct 2014
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X